Aarti Pharmalabs Limited (AARTIPHARM.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 57.58B |
| Enterprise Value | 65.02B |
| P/E Ratio | 35.36 |
| PEG Ratio | -1.86 |
| Price/Sales Ratio | 3.83 |
| Price/Book Ratio | 3.55 |
| Enterprise/Revenue | 3.83 |
| Enterprise/EBITDA | 16.77 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.17 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 18.19B |
| Revenue/Share | 217.22 |
| Gross Profit | 9.85B |
| EBITDA | 3.84B |
| Net Income | 1.75B |
| Diluted EPS | 19.25 |
Balance Sheet
| Total Cash | 96.16M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 234.38 |
Price History
| 52-Week Change | -0.84 |
| 52-Week High | 1,002.4 |
| 52-Week Low | 585 |
| Moving Average 50 Days | 870.22 |
| Moving Average 200 Days | 743.56 |
Statistics
| Average Volume | 852,948 |
| Shares Outstanding | 90.68M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.5 |
| Trailing Annual Dividend Yield | 0.42 |
| Payout Ratio | 0.11 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
